 |
 |

Percutaneous Absorption Following Topical Application of Neomycin
James D. Panzer, MD, PhD;
William L. Epstein, MD
Arch Dermatol. 1970;102(5):536-539.
Abstract
No percutaneous absorption was detected using a bioassay method sensitive to 0.0333µg/ml for serum following topical application of neomycin sulfate ointment in groups of normal male volunteers who had neomycin sulfate ointment applied to their bodies. Treatment areas ranged from coverage of all of the "wet" body areas on one side of the body to complete body coverage (excluding the genitalia) for a period of six hours. Results of urine and blood samples at various intervals were consistently negative for neomycin sulfate as determined by a sensitive bioassay method. No sensitization was found when subjects were patch and intradermally tested one to two months following treatment.
Author Affiliations
Kalamazoo, Mich; San Francisco
From Antibiotic Products Research, Pharmaceutical Marketing—Medical, The Upjohn Co, Kalamazoo, Mich (Dr. Panzer), and the Department of Dermatology, University of California San Francisco Medical Center (Dr. Epstein).
Footnotes
Accepted for publication Aug 8, 1970.
Reprint requests to Antibiotic Products Research, Pharmaceutical Marketing—Medical, The Upjohn Co, Kalamazoo, Mich 49001 (Dr. Panzer).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cross-Sensitivity of Common Aminoglycoside Antibiotics
Chung and Carson
Arch Dermatol 1976;112:1101-1107.
ABSTRACT
|